nodes	percent_of_prediction	percent_of_DWPC	metapath
Lapatinib—Nail disorder—Octreotide—thymus cancer	0.0223	0.0717	CcSEcCtD
Lapatinib—ERBB2—neck—thymus cancer	0.0203	0.0489	CbGeAlD
Lapatinib—PIK3C2B—hematopoietic system—thymus cancer	0.0195	0.0468	CbGeAlD
Lapatinib—Neoplasm malignant—Octreotide—thymus cancer	0.017	0.0545	CcSEcCtD
Lapatinib—Hyperbilirubinaemia—Octreotide—thymus cancer	0.0159	0.0511	CcSEcCtD
Lapatinib—TAP1—cardiac atrium—thymus cancer	0.0158	0.0379	CbGeAlD
Lapatinib—TAP1—pituitary gland—thymus cancer	0.0154	0.037	CbGeAlD
Lapatinib—ERBB2—hematopoietic system—thymus cancer	0.0151	0.0364	CbGeAlD
Lapatinib—PIK3C2B—cardiac atrium—thymus cancer	0.0148	0.0356	CbGeAlD
Lapatinib—PIK3C2B—pituitary gland—thymus cancer	0.0144	0.0347	CbGeAlD
Lapatinib—ERBB2—epithelium—thymus cancer	0.0138	0.0333	CbGeAlD
Lapatinib—ERBB4—epithelium—thymus cancer	0.0138	0.0333	CbGeAlD
Lapatinib—TAP1—bone marrow—thymus cancer	0.0133	0.032	CbGeAlD
Lapatinib—TAP1—thyroid gland—thymus cancer	0.0133	0.0319	CbGeAlD
Lapatinib—PIK3C2B—bone marrow—thymus cancer	0.0125	0.03	CbGeAlD
Lapatinib—PIK3C2B—thyroid gland—thymus cancer	0.0125	0.0299	CbGeAlD
Lapatinib—TAP1—lung—thymus cancer	0.012	0.029	CbGeAlD
Lapatinib—ERBB4—cardiac atrium—thymus cancer	0.0115	0.0276	CbGeAlD
Lapatinib—PIK3C2B—lung—thymus cancer	0.0113	0.0272	CbGeAlD
Lapatinib—ERBB4—pituitary gland—thymus cancer	0.0112	0.027	CbGeAlD
Lapatinib—Hot flush—Octreotide—thymus cancer	0.0112	0.0361	CcSEcCtD
Lapatinib—Menopausal symptoms—Octreotide—thymus cancer	0.0111	0.0358	CcSEcCtD
Lapatinib—PI4KB—cardiac atrium—thymus cancer	0.0108	0.0259	CbGeAlD
Lapatinib—ERBB2—lymphoid tissue—thymus cancer	0.0107	0.0256	CbGeAlD
Lapatinib—PI4KB—pituitary gland—thymus cancer	0.0105	0.0253	CbGeAlD
Lapatinib—Pain in extremity—Octreotide—thymus cancer	0.0105	0.0338	CcSEcCtD
Lapatinib—Dehydration—Octreotide—thymus cancer	0.00977	0.0314	CcSEcCtD
Lapatinib—ERBB2—thyroid gland—thymus cancer	0.00969	0.0233	CbGeAlD
Lapatinib—ERBB4—thyroid gland—thymus cancer	0.00969	0.0233	CbGeAlD
Lapatinib—Dry skin—Octreotide—thymus cancer	0.00963	0.0309	CcSEcCtD
Lapatinib—PI4KB—bone marrow—thymus cancer	0.0091	0.0219	CbGeAlD
Lapatinib—PI4KB—thyroid gland—thymus cancer	0.00907	0.0218	CbGeAlD
Lapatinib—ERBB2—lung—thymus cancer	0.0088	0.0211	CbGeAlD
Lapatinib—ERBB4—lung—thymus cancer	0.0088	0.0211	CbGeAlD
Lapatinib—TAP1—lymph node—thymus cancer	0.00824	0.0198	CbGeAlD
Lapatinib—PI4KB—lung—thymus cancer	0.00824	0.0198	CbGeAlD
Lapatinib—EGFR—thyroid gland—thymus cancer	0.00821	0.0197	CbGeAlD
Lapatinib—Pneumonia—Octreotide—thymus cancer	0.00815	0.0262	CcSEcCtD
Lapatinib—Neuropathy peripheral—Octreotide—thymus cancer	0.00794	0.0255	CcSEcCtD
Lapatinib—PIK3C2B—lymph node—thymus cancer	0.00774	0.0186	CbGeAlD
Lapatinib—Hepatobiliary disease—Octreotide—thymus cancer	0.00766	0.0246	CcSEcCtD
Lapatinib—Epistaxis—Octreotide—thymus cancer	0.00764	0.0245	CcSEcCtD
Lapatinib—EGFR—lung—thymus cancer	0.00746	0.0179	CbGeAlD
Lapatinib—Cardiac disorder—Octreotide—thymus cancer	0.00675	0.0217	CcSEcCtD
Lapatinib—Immune system disorder—Octreotide—thymus cancer	0.00657	0.0211	CcSEcCtD
Lapatinib—Alopecia—Octreotide—thymus cancer	0.00642	0.0206	CcSEcCtD
Lapatinib—Mental disorder—Octreotide—thymus cancer	0.00637	0.0205	CcSEcCtD
Lapatinib—Malnutrition—Octreotide—thymus cancer	0.00633	0.0203	CcSEcCtD
Lapatinib—Back pain—Octreotide—thymus cancer	0.00612	0.0197	CcSEcCtD
Lapatinib—ERBB2—lymph node—thymus cancer	0.00602	0.0145	CbGeAlD
Lapatinib—Anaemia—Octreotide—thymus cancer	0.00585	0.0188	CcSEcCtD
Lapatinib—PI4KB—lymph node—thymus cancer	0.00564	0.0135	CbGeAlD
Lapatinib—Palpitations—Octreotide—thymus cancer	0.00559	0.018	CcSEcCtD
Lapatinib—Cough—Octreotide—thymus cancer	0.00552	0.0177	CcSEcCtD
Lapatinib—Arthralgia—Octreotide—thymus cancer	0.00539	0.0173	CcSEcCtD
Lapatinib—Myalgia—Octreotide—thymus cancer	0.00539	0.0173	CcSEcCtD
Lapatinib—Unspecified disorder of skin and subcutaneous tissue—Octreotide—thymus cancer	0.00535	0.0172	CcSEcCtD
Lapatinib—Anaphylactic shock—Octreotide—thymus cancer	0.00517	0.0166	CcSEcCtD
Lapatinib—Infection—Octreotide—thymus cancer	0.00513	0.0165	CcSEcCtD
Lapatinib—EGFR—lymph node—thymus cancer	0.0051	0.0123	CbGeAlD
Lapatinib—Nervous system disorder—Octreotide—thymus cancer	0.00507	0.0163	CcSEcCtD
Lapatinib—Skin disorder—Octreotide—thymus cancer	0.00502	0.0161	CcSEcCtD
Lapatinib—Anorexia—Octreotide—thymus cancer	0.00492	0.0158	CcSEcCtD
Lapatinib—CYP2C19—hematopoietic system—thymus cancer	0.00472	0.0113	CbGeAlD
Lapatinib—Musculoskeletal discomfort—Octreotide—thymus cancer	0.00471	0.0151	CcSEcCtD
Lapatinib—Insomnia—Octreotide—thymus cancer	0.00467	0.015	CcSEcCtD
Lapatinib—Dyspnoea—Octreotide—thymus cancer	0.0046	0.0148	CcSEcCtD
Lapatinib—Dyspepsia—Octreotide—thymus cancer	0.00455	0.0146	CcSEcCtD
Lapatinib—Decreased appetite—Octreotide—thymus cancer	0.00449	0.0144	CcSEcCtD
Lapatinib—Gastrointestinal disorder—Octreotide—thymus cancer	0.00446	0.0143	CcSEcCtD
Lapatinib—Fatigue—Octreotide—thymus cancer	0.00445	0.0143	CcSEcCtD
Lapatinib—Constipation—Octreotide—thymus cancer	0.00442	0.0142	CcSEcCtD
Lapatinib—Gastrointestinal pain—Octreotide—thymus cancer	0.00422	0.0136	CcSEcCtD
Lapatinib—CYP2C8—hematopoietic system—thymus cancer	0.00412	0.00989	CbGeAlD
Lapatinib—Abdominal pain—Octreotide—thymus cancer	0.00408	0.0131	CcSEcCtD
Lapatinib—Hypersensitivity—Octreotide—thymus cancer	0.00381	0.0122	CcSEcCtD
Lapatinib—CYP3A5—hematopoietic system—thymus cancer	0.00372	0.00893	CbGeAlD
Lapatinib—Asthenia—Octreotide—thymus cancer	0.00371	0.0119	CcSEcCtD
Lapatinib—Pruritus—Octreotide—thymus cancer	0.00365	0.0117	CcSEcCtD
Lapatinib—Diarrhoea—Octreotide—thymus cancer	0.00353	0.0114	CcSEcCtD
Lapatinib—Vomiting—Octreotide—thymus cancer	0.00328	0.0106	CcSEcCtD
Lapatinib—Rash—Octreotide—thymus cancer	0.00326	0.0105	CcSEcCtD
Lapatinib—Dermatitis—Octreotide—thymus cancer	0.00325	0.0105	CcSEcCtD
Lapatinib—Headache—Octreotide—thymus cancer	0.00324	0.0104	CcSEcCtD
Lapatinib—Nausea—Octreotide—thymus cancer	0.00307	0.00986	CcSEcCtD
Lapatinib—CYP2C8—pituitary gland—thymus cancer	0.00305	0.00734	CbGeAlD
Lapatinib—CYP3A4—hematopoietic system—thymus cancer	0.00279	0.0067	CbGeAlD
Lapatinib—CYP3A5—lung—thymus cancer	0.00216	0.00519	CbGeAlD
Lapatinib—ABCB1—hematopoietic system—thymus cancer	0.00197	0.00474	CbGeAlD
Lapatinib—ABCB1—epithelium—thymus cancer	0.0018	0.00434	CbGeAlD
Lapatinib—ABCB1—pituitary gland—thymus cancer	0.00146	0.00352	CbGeAlD
Lapatinib—ERBB2—DAP12 signaling—KIT—thymus cancer	0.00139	0.0051	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—KIT—thymus cancer	0.00139	0.0051	CbGpPWpGaD
Lapatinib—ABCB1—lymphoid tissue—thymus cancer	0.00139	0.00334	CbGeAlD
Lapatinib—ERBB2—Innate Immune System—CYLD—thymus cancer	0.00139	0.00508	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—KIT—thymus cancer	0.00138	0.00507	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—KIT—thymus cancer	0.00138	0.00505	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.00137	0.00502	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—KIT—thymus cancer	0.00137	0.00502	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CYLD—thymus cancer	0.00137	0.00501	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.00135	0.00495	CbGpPWpGaD
Lapatinib—EGFR—E-cadherin signaling in keratinocytes—AKT1—thymus cancer	0.00133	0.00487	CbGpPWpGaD
Lapatinib—PIK3C2B—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.00132	0.00482	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—KIT—thymus cancer	0.00131	0.0048	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—KIT—thymus cancer	0.00131	0.0048	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.00131	0.0048	CbGpPWpGaD
Lapatinib—EGFR—Aryl Hydrocarbon Receptor Pathway—IL2—thymus cancer	0.00131	0.00479	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—KIT—thymus cancer	0.0013	0.00476	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—KIT—thymus cancer	0.0013	0.00475	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.00129	0.00472	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—KIT—thymus cancer	0.00129	0.00472	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—KIT—thymus cancer	0.00129	0.00472	CbGpPWpGaD
Lapatinib—ERBB2—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.00129	0.00471	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—KIT—thymus cancer	0.00128	0.00471	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—KIT—thymus cancer	0.00128	0.00469	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—KIT—thymus cancer	0.00128	0.00468	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—KIT—thymus cancer	0.00127	0.00464	CbGpPWpGaD
Lapatinib—ABCB1—bone marrow—thymus cancer	0.00127	0.00304	CbGeAlD
Lapatinib—ABCB1—thyroid gland—thymus cancer	0.00126	0.00303	CbGeAlD
Lapatinib—ERBB4—Signaling by PDGF—KIT—thymus cancer	0.00126	0.00462	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—KIT—thymus cancer	0.00121	0.00444	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—KIT—thymus cancer	0.00119	0.00437	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.00116	0.00425	CbGpPWpGaD
Lapatinib—EGFR—Bladder Cancer—TP53—thymus cancer	0.00115	0.00422	CbGpPWpGaD
Lapatinib—EGFR—Gastric Cancer Network 2—TP53—thymus cancer	0.00115	0.00422	CbGpPWpGaD
Lapatinib—ABCB1—lung—thymus cancer	0.00115	0.00276	CbGeAlD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.00114	0.00418	CbGpPWpGaD
Lapatinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—KIT—thymus cancer	0.00113	0.00413	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways in Glioblastoma—TP53—thymus cancer	0.00109	0.00401	CbGpPWpGaD
Lapatinib—EGFR—SHP2 signaling—IL2—thymus cancer	0.00109	0.00398	CbGpPWpGaD
Lapatinib—ERBB2—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.00109	0.00398	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD8A—thymus cancer	0.00105	0.00385	CbGpPWpGaD
Lapatinib—EGFR—PI-3K cascade—KIT—thymus cancer	0.00101	0.00372	CbGpPWpGaD
Lapatinib—EGFR—Extracellular vesicle-mediated signaling in recipient cells—AKT1—thymus cancer	0.000998	0.00366	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—CD4—thymus cancer	0.000993	0.00364	CbGpPWpGaD
Lapatinib—ERBB2—Leptin signaling pathway—AKT1—thymus cancer	0.000992	0.00364	CbGpPWpGaD
Lapatinib—EGFR—PI3K/AKT activation—KIT—thymus cancer	0.000991	0.00363	CbGpPWpGaD
Lapatinib—EGFR—GAB1 signalosome—KIT—thymus cancer	0.000983	0.0036	CbGpPWpGaD
Lapatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—KIT—thymus cancer	0.00096	0.00352	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Telomerase—IL2—thymus cancer	0.000957	0.00351	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—CDKN2A—thymus cancer	0.00095	0.00348	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways in Glioblastoma—AKT1—thymus cancer	0.000924	0.00339	CbGpPWpGaD
Lapatinib—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—KIT—thymus cancer	0.000892	0.00327	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—KIT—thymus cancer	0.000891	0.00327	CbGpPWpGaD
Lapatinib—ERBB2—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.000889	0.00326	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—KIT—thymus cancer	0.000878	0.00322	CbGpPWpGaD
Lapatinib—ERBB4—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.000876	0.00321	CbGpPWpGaD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—TP53—thymus cancer	0.000871	0.00319	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CYLD—thymus cancer	0.000807	0.00296	CbGpPWpGaD
Lapatinib—ERBB2—PI-3K cascade—AKT1—thymus cancer	0.000801	0.00294	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CYLD—thymus cancer	0.000795	0.00292	CbGpPWpGaD
Lapatinib—ERBB4—PI-3K cascade—AKT1—thymus cancer	0.000789	0.00289	CbGpPWpGaD
Lapatinib—TAP1—Immune System—KIT—thymus cancer	0.000788	0.00289	CbGpPWpGaD
Lapatinib—ABCB1—lymph node—thymus cancer	0.000784	0.00188	CbGeAlD
Lapatinib—ERBB2—PI3K/AKT activation—AKT1—thymus cancer	0.000782	0.00287	CbGpPWpGaD
Lapatinib—ERBB2—GAB1 signalosome—AKT1—thymus cancer	0.000776	0.00284	CbGpPWpGaD
Lapatinib—ERBB4—PI3K/AKT activation—AKT1—thymus cancer	0.00077	0.00282	CbGpPWpGaD
Lapatinib—ERBB4—GAB1 signalosome—AKT1—thymus cancer	0.000764	0.0028	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—KIT—thymus cancer	0.000758	0.00278	CbGpPWpGaD
Lapatinib—ERBB2—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.000758	0.00278	CbGpPWpGaD
Lapatinib—ERBB4—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.000747	0.00274	CbGpPWpGaD
Lapatinib—EGFR—ErbB Signaling Pathway—TP53—thymus cancer	0.000739	0.00271	CbGpPWpGaD
Lapatinib—ERBB2—DNA Damage Response (only ATM dependent)—AKT1—thymus cancer	0.000736	0.0027	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—KIT—thymus cancer	0.000726	0.00266	CbGpPWpGaD
Lapatinib—EGFR—a6b1 and a6b4 Integrin signaling—AKT1—thymus cancer	0.000722	0.00265	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—KIT—thymus cancer	0.000714	0.00262	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—KIT—thymus cancer	0.000682	0.0025	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—KIT—thymus cancer	0.000679	0.00249	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—KIT—thymus cancer	0.000675	0.00248	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—KIT—thymus cancer	0.000672	0.00246	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CYLD—thymus cancer	0.00067	0.00246	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—KIT—thymus cancer	0.000662	0.00243	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD8A—thymus cancer	0.00065	0.00238	CbGpPWpGaD
Lapatinib—EGFR—Signaling events mediated by PTP1B—AKT1—thymus cancer	0.000643	0.00236	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD8A—thymus cancer	0.00064	0.00235	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—KIT—thymus cancer	0.000632	0.00232	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—KIT—thymus cancer	0.000632	0.00232	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—KIT—thymus cancer	0.000632	0.00232	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—KIT—thymus cancer	0.000627	0.0023	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—TP53—thymus cancer	0.000622	0.00228	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—KIT—thymus cancer	0.000621	0.00228	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—KIT—thymus cancer	0.000618	0.00227	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—IL2—thymus cancer	0.000615	0.00226	CbGpPWpGaD
Lapatinib—EGFR—Thromboxane A2 receptor signaling—AKT1—thymus cancer	0.000606	0.00222	CbGpPWpGaD
Lapatinib—TAP1—Immune System—CD4—thymus cancer	0.000603	0.00221	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by SCF-KIT—AKT1—thymus cancer	0.000599	0.0022	CbGpPWpGaD
Lapatinib—ERBB2—Disease—MAML2—thymus cancer	0.000592	0.00217	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by SCF-KIT—AKT1—thymus cancer	0.00059	0.00216	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—KIT—thymus cancer	0.000585	0.00215	CbGpPWpGaD
Lapatinib—ERBB4—Disease—MAML2—thymus cancer	0.000583	0.00214	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000573	0.0021	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000564	0.00207	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB4—AKT1—thymus cancer	0.000564	0.00207	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—KIT—thymus cancer	0.00056	0.00205	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000556	0.00204	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB4—AKT1—thymus cancer	0.000555	0.00204	CbGpPWpGaD
Lapatinib—TAP1—Immune System—IL2—thymus cancer	0.000554	0.00203	CbGpPWpGaD
Lapatinib—EGFR—LPA receptor mediated events—AKT1—thymus cancer	0.000544	0.002	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signal transduction—AKT1—thymus cancer	0.000538	0.00197	CbGpPWpGaD
Lapatinib—ERBB2—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000536	0.00196	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR—AKT1—thymus cancer	0.000536	0.00196	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by ERBB2—AKT1—thymus cancer	0.000533	0.00195	CbGpPWpGaD
Lapatinib—EGFR—AGE/RAGE pathway—AKT1—thymus cancer	0.000531	0.00195	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 signaling—AKT1—thymus cancer	0.000531	0.00195	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signal transduction—AKT1—thymus cancer	0.00053	0.00194	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—TP53—thymus cancer	0.000529	0.00194	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR—AKT1—thymus cancer	0.000528	0.00194	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by ERBB2—AKT1—thymus cancer	0.000525	0.00193	CbGpPWpGaD
Lapatinib—EGFR—Rac1/Pak1/p38/MMP-2 pathway—AKT1—thymus cancer	0.000525	0.00192	CbGpPWpGaD
Lapatinib—ERBB2—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000523	0.00192	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 signaling—AKT1—thymus cancer	0.000523	0.00192	CbGpPWpGaD
Lapatinib—EGFR—Regulation of Telomerase—AKT1—thymus cancer	0.000519	0.0019	CbGpPWpGaD
Lapatinib—ERBB4—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000515	0.00189	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—KIT—thymus cancer	0.000508	0.00186	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—KIT—thymus cancer	0.000501	0.00184	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by FGFR in disease—AKT1—thymus cancer	0.000499	0.00183	CbGpPWpGaD
Lapatinib—ERBB2—DAP12 interactions—AKT1—thymus cancer	0.000499	0.00183	CbGpPWpGaD
Lapatinib—ERBB2—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000499	0.00183	CbGpPWpGaD
Lapatinib—TAP1—Adaptive Immune System—AKT1—thymus cancer	0.000496	0.00182	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR—AKT1—thymus cancer	0.000495	0.00181	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by FGFR in disease—AKT1—thymus cancer	0.000492	0.0018	CbGpPWpGaD
Lapatinib—ERBB4—DAP12 interactions—AKT1—thymus cancer	0.000492	0.0018	CbGpPWpGaD
Lapatinib—ERBB4—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000492	0.0018	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.00049	0.0018	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by PDGF—AKT1—thymus cancer	0.000488	0.00179	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—KIT—thymus cancer	0.000488	0.00179	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR—AKT1—thymus cancer	0.000487	0.00179	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000483	0.00177	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by PDGF—AKT1—thymus cancer	0.000481	0.00176	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—KIT—thymus cancer	0.000481	0.00176	CbGpPWpGaD
Lapatinib—ERBB2—Focal Adhesion—AKT1—thymus cancer	0.000472	0.00173	CbGpPWpGaD
Lapatinib—ERBB2—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.00047	0.00172	CbGpPWpGaD
Lapatinib—ERBB2—B Cell Activation—AKT1—thymus cancer	0.000462	0.00169	CbGpPWpGaD
Lapatinib—ERBB4—B Cell Activation—AKT1—thymus cancer	0.000455	0.00167	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways in Glioblastoma—AKT1—thymus cancer	0.000447	0.00164	CbGpPWpGaD
Lapatinib—ERBB2—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000442	0.00162	CbGpPWpGaD
Lapatinib—ERBB4—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000435	0.0016	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—KIT—thymus cancer	0.000431	0.00158	CbGpPWpGaD
Lapatinib—EGFR—Constitutive PI3K/AKT Signaling in Cancer—AKT1—thymus cancer	0.00043	0.00158	CbGpPWpGaD
Lapatinib—ABCB1—Allograft Rejection—IL2—thymus cancer	0.000428	0.00157	CbGpPWpGaD
Lapatinib—EGFR—Androgen receptor signaling pathway—AKT1—thymus cancer	0.000418	0.00153	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—MAML2—thymus cancer	0.000415	0.00152	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—MAML2—thymus cancer	0.000408	0.0015	CbGpPWpGaD
Lapatinib—EGFR—Spinal Cord Injury—TP53—thymus cancer	0.000395	0.00145	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD8A—thymus cancer	0.000394	0.00145	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CYLD—thymus cancer	0.00039	0.00143	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—CD4—thymus cancer	0.000389	0.00143	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD8A—thymus cancer	0.000388	0.00142	CbGpPWpGaD
Lapatinib—EGFR—PI-3K cascade—AKT1—thymus cancer	0.000387	0.00142	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—CD4—thymus cancer	0.000383	0.0014	CbGpPWpGaD
Lapatinib—EGFR—PI3K/AKT activation—AKT1—thymus cancer	0.000378	0.00139	CbGpPWpGaD
Lapatinib—EGFR—GAB1 signalosome—AKT1—thymus cancer	0.000375	0.00138	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—CD4—thymus cancer	0.000373	0.00137	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—CD4—thymus cancer	0.000368	0.00135	CbGpPWpGaD
Lapatinib—EGFR—ErbB1 downstream signaling—AKT1—thymus cancer	0.000366	0.00134	CbGpPWpGaD
Lapatinib—EGFR—Role of LAT2/NTAL/LAB on calcium mobilization—AKT1—thymus cancer	0.000366	0.00134	CbGpPWpGaD
Lapatinib—EGFR—Direct p53 effectors—TP53—thymus cancer	0.000345	0.00126	CbGpPWpGaD
Lapatinib—ERBB2—Signaling by NGF—AKT1—thymus cancer	0.00034	0.00125	CbGpPWpGaD
Lapatinib—ERBB4—Signaling by NGF—AKT1—thymus cancer	0.000335	0.00123	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—TP53—thymus cancer	0.000324	0.00119	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD8A—thymus cancer	0.000314	0.00115	CbGpPWpGaD
Lapatinib—TAP1—Immune System—AKT1—thymus cancer	0.000301	0.0011	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—TP53—thymus cancer	0.000298	0.00109	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—KIT—thymus cancer	0.000296	0.00109	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—KIT—thymus cancer	0.000292	0.00107	CbGpPWpGaD
Lapatinib—EGFR—Signaling by SCF-KIT—AKT1—thymus cancer	0.000289	0.00106	CbGpPWpGaD
Lapatinib—EGFR—Disease—MAML2—thymus cancer	0.000286	0.00105	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling of activated FGFR—AKT1—thymus cancer	0.000277	0.00102	CbGpPWpGaD
Lapatinib—EGFR—Integrated Breast Cancer Pathway—AKT1—thymus cancer	0.000274	0.001	CbGpPWpGaD
Lapatinib—ERBB2—Disease—KIT—thymus cancer	0.000273	0.001	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB4—AKT1—thymus cancer	0.000273	0.000999	CbGpPWpGaD
Lapatinib—ERBB4—Disease—KIT—thymus cancer	0.000269	0.000987	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000269	0.000986	CbGpPWpGaD
Lapatinib—ABCB1—HIF-1-alpha transcription factor network—AKT1—thymus cancer	0.000268	0.000983	CbGpPWpGaD
Lapatinib—EGFR—Downstream signal transduction—AKT1—thymus cancer	0.00026	0.000954	CbGpPWpGaD
Lapatinib—EGFR—EGF/EGFR Signaling Pathway—AKT1—thymus cancer	0.000259	0.00095	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR—AKT1—thymus cancer	0.000259	0.00095	CbGpPWpGaD
Lapatinib—EGFR—Signaling by ERBB2—AKT1—thymus cancer	0.000258	0.000945	CbGpPWpGaD
Lapatinib—EGFR—DAP12 signaling—AKT1—thymus cancer	0.000256	0.00094	CbGpPWpGaD
Lapatinib—EGFR—Downstream signaling events of B Cell Receptor (BCR)—AKT1—thymus cancer	0.000253	0.000927	CbGpPWpGaD
Lapatinib—EGFR—MAPK Signaling Pathway—AKT1—thymus cancer	0.000252	0.000922	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—KIT—thymus cancer	0.000246	0.000901	CbGpPWpGaD
Lapatinib—EGFR—Signaling by FGFR in disease—AKT1—thymus cancer	0.000241	0.000885	CbGpPWpGaD
Lapatinib—EGFR—DAP12 interactions—AKT1—thymus cancer	0.000241	0.000885	CbGpPWpGaD
Lapatinib—EGFR—Fc epsilon receptor (FCERI) signaling—AKT1—thymus cancer	0.000241	0.000885	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR—AKT1—thymus cancer	0.000239	0.000877	CbGpPWpGaD
Lapatinib—EGFR—Signaling by EGFR in Cancer—AKT1—thymus cancer	0.000237	0.000869	CbGpPWpGaD
Lapatinib—EGFR—Signaling by PDGF—AKT1—thymus cancer	0.000236	0.000865	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—KIT—thymus cancer	0.000236	0.000865	CbGpPWpGaD
Lapatinib—EGFR—Focal Adhesion—AKT1—thymus cancer	0.000228	0.000836	CbGpPWpGaD
Lapatinib—EGFR—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000227	0.000832	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—CD4—thymus cancer	0.000226	0.00083	CbGpPWpGaD
Lapatinib—EGFR—B Cell Activation—AKT1—thymus cancer	0.000223	0.000819	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—CD4—thymus cancer	0.000223	0.000818	CbGpPWpGaD
Lapatinib—ERBB2—Developmental Biology—AKT1—thymus cancer	0.00022	0.000805	CbGpPWpGaD
Lapatinib—PIK3C2B—Metabolism—AKT1—thymus cancer	0.000215	0.000787	CbGpPWpGaD
Lapatinib—EGFR—NGF signalling via TRKA from the plasma membrane—AKT1—thymus cancer	0.000214	0.000784	CbGpPWpGaD
Lapatinib—ERBB2—Disease—CD4—thymus cancer	0.000209	0.000766	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—IL2—thymus cancer	0.000208	0.000764	CbGpPWpGaD
Lapatinib—PI4KB—Metabolism—AKT1—thymus cancer	0.000207	0.00076	CbGpPWpGaD
Lapatinib—ERBB4—Disease—CD4—thymus cancer	0.000206	0.000755	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—IL2—thymus cancer	0.000205	0.000752	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—MAML2—thymus cancer	0.0002	0.000735	CbGpPWpGaD
Lapatinib—ERBB2—Innate Immune System—AKT1—thymus cancer	0.000194	0.000711	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—KIT—thymus cancer	0.000191	0.000702	CbGpPWpGaD
Lapatinib—ERBB4—Innate Immune System—AKT1—thymus cancer	0.000191	0.0007	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD8A—thymus cancer	0.000191	0.000699	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—KIT—thymus cancer	0.000189	0.000691	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—CD4—thymus cancer	0.000188	0.000689	CbGpPWpGaD
Lapatinib—ERBB2—Adaptive Immune System—AKT1—thymus cancer	0.000186	0.000683	CbGpPWpGaD
Lapatinib—ERBB4—Adaptive Immune System—AKT1—thymus cancer	0.000183	0.000673	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—CD4—thymus cancer	0.00018	0.000662	CbGpPWpGaD
Lapatinib—EGFR—Signaling by NGF—AKT1—thymus cancer	0.000164	0.000603	CbGpPWpGaD
Lapatinib—EGFR—Immune System—KIT—thymus cancer	0.000143	0.000525	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—thymus cancer	0.000136	0.000498	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—IL2—thymus cancer	0.000135	0.000494	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—IL2—thymus cancer	0.000133	0.000486	CbGpPWpGaD
Lapatinib—EGFR—Disease—KIT—thymus cancer	0.000132	0.000484	CbGpPWpGaD
Lapatinib—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—thymus cancer	0.000115	0.00042	CbGpPWpGaD
Lapatinib—ERBB2—Immune System—AKT1—thymus cancer	0.000113	0.000414	CbGpPWpGaD
Lapatinib—ERBB4—Immune System—AKT1—thymus cancer	0.000111	0.000408	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—IL2—thymus cancer	0.00011	0.000404	CbGpPWpGaD
Lapatinib—EGFR—Immune System—CD4—thymus cancer	0.000109	0.000401	CbGpPWpGaD
Lapatinib—EGFR—Developmental Biology—AKT1—thymus cancer	0.000106	0.000389	CbGpPWpGaD
Lapatinib—ERBB2—Disease—AKT1—thymus cancer	0.000104	0.000382	CbGpPWpGaD
Lapatinib—ERBB4—Disease—AKT1—thymus cancer	0.000103	0.000377	CbGpPWpGaD
Lapatinib—EGFR—Disease—CD4—thymus cancer	0.000101	0.000371	CbGpPWpGaD
Lapatinib—EGFR—Immune System—IL2—thymus cancer	0.000101	0.000369	CbGpPWpGaD
Lapatinib—EGFR—Innate Immune System—AKT1—thymus cancer	9.38e-05	0.000344	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—KIT—thymus cancer	9.25e-05	0.000339	CbGpPWpGaD
Lapatinib—EGFR—Adaptive Immune System—AKT1—thymus cancer	9e-05	0.00033	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—TP53—thymus cancer	8.65e-05	0.000317	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—TP53—thymus cancer	8.52e-05	0.000312	CbGpPWpGaD
Lapatinib—ERBB2—Signaling Pathways—AKT1—thymus cancer	7.3e-05	0.000268	CbGpPWpGaD
Lapatinib—ERBB4—Signaling Pathways—AKT1—thymus cancer	7.19e-05	0.000264	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—IL2—thymus cancer	6.51e-05	0.000239	CbGpPWpGaD
Lapatinib—EGFR—Signaling by GPCR—AKT1—thymus cancer	5.98e-05	0.000219	CbGpPWpGaD
Lapatinib—EGFR—Immune System—AKT1—thymus cancer	5.46e-05	0.0002	CbGpPWpGaD
Lapatinib—EGFR—Disease—AKT1—thymus cancer	5.04e-05	0.000185	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—TP53—thymus cancer	4.18e-05	0.000153	CbGpPWpGaD
Lapatinib—EGFR—Signaling Pathways—AKT1—thymus cancer	3.53e-05	0.000129	CbGpPWpGaD
Lapatinib—CYP3A5—Metabolism—AKT1—thymus cancer	2.82e-05	0.000104	CbGpPWpGaD
Lapatinib—CYP2C8—Metabolism—AKT1—thymus cancer	2.45e-05	8.97e-05	CbGpPWpGaD
Lapatinib—CYP2C19—Metabolism—AKT1—thymus cancer	2.18e-05	8.01e-05	CbGpPWpGaD
Lapatinib—ABCB1—Metabolism—AKT1—thymus cancer	2.13e-05	7.81e-05	CbGpPWpGaD
Lapatinib—CYP3A4—Metabolism—AKT1—thymus cancer	1.31e-05	4.81e-05	CbGpPWpGaD
